What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
Rik J. Scheper spends much of his time researching Immunology, Molecular biology, Pathology, P-glycoprotein and Multiple drug resistance.
His research on Immunology often connects related areas such as Cancer research.
His Molecular biology study integrates concerns from other disciplines, such as FANCF, CD40, FANCA, Transmembrane protein and Membrane glycoproteins.
His Pathology research includes themes of ABCC6 and Drug resistance.
His studies deal with areas such as Daunorubicin, NeuN, Transport protein and Blood–brain barrier as well as P-glycoprotein.
Rik J. Scheper combines subjects such as Cell culture, Internal medicine, Gene and Multidrug resistance-associated protein 2 with his study of Multiple drug resistance.
His most cited work include:
- Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. (765 citations)
- The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria (674 citations)
- The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. (601 citations)
What are the main themes of his work throughout his whole career to date?
Rik J. Scheper mostly deals with Immunology, Cancer research, Molecular biology, Cell biology and T cell.
His Cancer research research is multidisciplinary, incorporating elements of Cell culture, P-glycoprotein, Multiple drug resistance, Pathology and Immunotherapy.
His work carried out in the field of P-glycoprotein brings together such families of science as Daunorubicin and Abcg2.
His Multiple drug resistance research incorporates elements of Efflux and Pharmacology.
In his study, Immunohistochemistry is strongly linked to Monoclonal antibody, which falls under the umbrella field of Molecular biology.
The various areas that Rik J. Scheper examines in his T cell study include T lymphocyte and Cytokine.
He most often published in these fields:
- Immunology (47.10%)
- Cancer research (18.71%)
- Molecular biology (18.39%)
What were the highlights of his more recent work (between 2006-2021)?
- Immunology (47.10%)
- Cell biology (13.87%)
- Cancer research (18.71%)
In recent papers he was focusing on the following fields of study:
Rik J. Scheper mainly investigates Immunology, Cell biology, Cancer research, Immunotherapy and T cell.
His Cytotoxic T cell research extends to Immunology, which is thematically connected.
His Cell biology research incorporates themes from Langerhans cell, Cell culture, Keratinocyte, Dermis and Human skin.
His research on Dermis also deals with topics like
- Epidermis which intersects with area such as Molecular biology,
- Basement membrane and Pathology most often made with reference to Wound healing.
His research integrates issues of Proteasome inhibitor, Bortezomib, Renal cell carcinoma and CD40 in his study of Cancer research.
His study looks at the relationship between Immunotherapy and fields such as Prostate cancer, as well as how they intersect with chemical problems.
Between 2006 and 2021, his most popular works were:
- Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein (339 citations)
- Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial (290 citations)
- Low Levels of Circulating Invariant Natural Killer T Cells Predict Poor Clinical Outcome in Patients With Head and Neck Squamous Cell Carcinoma (154 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
The scientist’s investigation covers issues in Immunology, Cell biology, Dendritic cell, Immune system and Immunotherapy.
His Immunology study incorporates themes from Cancer, Cancer research, In vitro, Dermis and Epidermis.
His research investigates the connection between Cancer research and topics such as PSMB6 that intersect with problems in Proteasome inhibitor.
His work carried out in the field of Cell biology brings together such families of science as Cell culture, CCL21, Pathology, CXC chemokine receptors and Human skin.
Rik J. Scheper has included themes like Oral administration, Placebo, Hepatitis and Sensitization in his Immune system study.
His Molecular biology research focuses on Proteasome and how it relates to T cell and Cytokine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
